HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD.
发明人:
Rifaat SAFADI
申请号：
US15562602
公开号：
US20180111989A1
申请日:
2016.03.31
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Provided is a method for treating, attenuating and/or preventing progression of a liver disorder in a subject, the method including administering a therapeutically effective amount of an agent capable of interfering with, inhibiting and/or preventing neuroligin 4 (NLGn4)-Neurexin 1-beta (Nrx1b) protein-protein interaction. Also provided are compositions including the agent.
